ROSEVILLE, Minn., May 17, 2022 /PRNewswire/ -- Calyxt, Inc. CLXT, a plant-based synthetic biology company, today announced that management will participate in the following upcoming investor conferences:
H.C. Wainwright Global Investment Conference
Date: May 25, 2022
Time: 11:30 am ET
Webcast: https://journey.ct.events/view/dd5ae7e1-6b52-430b-b9d8-504d330d80ad
LD Micro Invitational (XII)
Date: June 8, 2022
Time: 7:30 am ET
Webcast: https://ldinv12.mysequire.com
To schedule a meeting with management, please reach out to investors@calyxt.com.
The presentations will be available for viewing and replay from the Investors section of Calyxt's website at www.calyxt.com.
About Calyxt
Calyxt CLXT is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.
Contacts
Calyxt Media Contact: | Calyxt Investor Relations Contact: | |
David Rosen/ John Garabo/ Michael Barron Argot Partners (212) 600-1902 | Kimberly Minarovich/ Cameron Willis (212) 600-1902 | |
Calyxt Business Development Contact: | ||
Gerry Nuovo Senior Vice President of Business Development (612) 427-7881 |
SOURCE Calyxt, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.